Corroborating our bioinformatic predictions, IHC results confirmed that ZNF668 protein levels were significantly elevated in BRCA, COAD, GBM, LUAD, and OV, while conversely being significantly decreased in PAAD and THCA (Figure 11A,B). Here, ZNF668 is linked to glioblastoma.